Neuroprosthetics Market Size To Reach $47.0 Billion By 2033

Neuroprosthetics Market Growth & Trends

The global neuroprosthetics market size is expected to reach USD 47.0 billion by 2033, registering a CAGR of 13.69% from 2025 to 2033, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years. 

In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth. 

Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth.

 Request a free sample copy or view report summary: Neuroprosthetics Market Report

Neuroprosthetics Market Report Highlights

• The motor prosthetics segment held the largest share of the market, accounting for 43.09% of total revenue in 2024.

• The motor neuron disorders segment accounted for the largest share of the market in 2024. This is mainly because more people are being diagnosed with conditions like Parkinson’s disease and epilepsy worldwide.

• The Spinal Cord Stimulation (SCS) segment dominated the market in 2024, accounting for the largest share. This dominance is primarily driven by the increasing prevalence of chronic pain globally.

• North America neuroproethetics industry accounted for the largest share of 42.50% of the global market in 2024.This is mainly a result of the rising occurrence of neurological disorders and the expanding elderly population in the region.

Neuroprosthetics Market Segmentation

Grand View Research has segmented the global neuroprosthetics market on the basis of on type, technology, application, and region:

Neuroprosthetics Type Outlook (Revenue, USD Million, 2021 - 2033)

• Motor Prosthetics

• Cochlear Implants

• Cognitive Prosthetics

• Retinal Implants

Neuroprosthetics Technology Outlook (Revenue, USD Million, 2021 - 2033)

• Deep Brain Stimulation (DBS)

• Vagus Nerve Stimulation (VNS)

• Spinal Cord Stimulation (SCS)

• Sacral Nerve Stimulation (SNS)

Neuroprosthetics Application Outlook (Revenue, USD Million, 2021 - 2033)

• Motor Neuron Disorders

  • Parkinson’s Disease

  • Epilepsy

• Physiological Disorders

  • Auditory Disorders

  • Opthalmic Disorders

  • Cardiac Disorders

  • Kidney Disorders

• Cognitive Disorders

  • Alzheimer’s Disease

  • Severe Depression

Neuroprosthetics Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Neuroprosthetics Market

• Medtronic

• LivaNova PLC

• Cochlear Ltd.

• Abbott

• Boston Scientific Corporation

• Nevro Corp

• Sonova

• Science Corporation

• Advanced Bionics AG

• MED-EL Medical Electronics

• ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.